Skip to main content
OpenTrials

Clinical trial condition

Breast Ductal Carcinoma in Situ

Explore clinical trials studying Breast Ductal Carcinoma in Situ. Study availability and eligibility vary by location and protocol.

21 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Breast Ductal Carcinoma in Situ trial results

Completed

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy

NCT00769379

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Ductal Carcinoma in Situ, +7 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 1260 locations
View Trial Details
Completed

Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer

NCT02636582

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Ductal Carcinoma in Situ, +7 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

NCT01272037

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Ductal Carcinoma in Situ, +11 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
View all 1569 locations
View Trial Details

Related conditions